Target intelligence / Profile preview

PEAK family member 3 (PEAK3)

Target
PEAK3
Molecular classification
Pseudokinase, Molecular scaffold, New Kinase Family 3 (NKF3)
01

Overview

PEAK family member 3 (PEAK3) is a pseudokinase and molecular scaffold protein, part of the PEAK family (NKF3) along with PEAK1 and PEAK2/Pragmin[1][4][5]. PEAK3 is structurally similar to other family members but is unique in its domain features and binding interfaces, including a fully resolved activation loop and αC helix. It acts as a signaling hub downstream of growth factor stimulation and is dynamically regulated by phosphorylation, especially through interactions with 14-3-3 proteins, CrkII, and other scaffold/adaptor proteins. PEAK3 dimerizes through a conserved SHED domain, forming homo- and heterodimers. Functionally, PEAK3 controls cell motility, migration, and morphology, and its overexpression has been shown to promote invasive, oncogenic behaviors in several cancer cell models. Recent cryo-EM studies highlight its complex with regulatory proteins such as 14-3-3, impacting localization and interactome diversity. PEAK3 is increasingly viewed as an important disease target, particularly in oncology, though no therapeutic interventions have yet been reported[1][3][4][5].

Other names
C19orf35Chromosome 19 open reading frame 35FLJ45778Protein PEAK3PEAK3
02

Biological functions

Protein scaffoldingRegulation of cell motilityRegulation of cell migrationControl of cell morphologySignal transduction (EGFR pathway)Regulation of cell proliferation
03

Disease associations

Cancer (especially breast cancer, acute myeloid leukemia)Cell migration/invasion (related to oncogenic transformation)
04

Safety considerations

Potential risks related to targeting scaffolding functions in normal cells, where PEAK3 regulates cell homeostasis and migrationUnknown off-target effects due to broad signaling network interactions
05

Biomarkers

PEAK3 overexpression in cancer cells (breast cancer, AML)Phosphorylation status of PEAK3

Beyond the preview

Go deeper on PEAK family member 3 (PEAK3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PEAK family member 3 (PEAK3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call